Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$0.96 - $1.74 $576,000 - $1.04 Million
-600,000 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$0.67 - $0.96 $402,000 - $576,000
600,000 New
600,000 $460,000
Q3 2020

Oct 29, 2020

SELL
$0.67 - $0.96 $402,000 - $576,000
-600,000 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$0.52 - $0.92 $312,000 - $552,000
600,000 New
600,000 $464,000
Q1 2020

May 15, 2020

SELL
$0.6 - $2.31 $120,000 - $462,000
-200,000 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$0.63 - $2.27 $126,000 - $454,000
200,000 New
200,000 $454,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.